# Vincent Bours

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vincent-bours/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,044 |
| Field | NF-κB Signaling Pathways |
| h-index | 75 |
| i10-index | 221 |
| Last Known Institution | University of Liège |
| OpenAlex ID | https://openalex.org/A5083510035 |
| ORCID iD | https://orcid.org/0000-0002-5934-6247 |
| Works | 493 |

## Researcher papers

- [Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study](https://scholariq.org/papers/clinical-characteristics-and-therapeutic-responses-in-patients-with-germ-line-i/)
- [Transcriptome analysis reveals tumor microenvironment changes in glioblastoma](https://scholariq.org/papers/transcriptome-analysis-reveals-tumor-microenvironment-changes-in-glioblastoma/)
- [Nuclear factor-κB, cancer, and apoptosis](https://scholariq.org/papers/nuclear-factor-b-cancer-and-apoptosis/)
- [Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults](https://scholariq.org/papers/early-termination-of-isrctn45828668-a-phase-1-2-prospective-randomized-study-of/)
- [<b> <i>In vitro</i> </b> and <b> <i>In vivo</i> </b> Activity of the Nuclear Factor-κB Inhibitor Sulfasalazine in Human Glioblastomas](https://scholariq.org/papers/b-i-in-vitro-i-b-and-b-i-in-vivo-i-b-activity-of-the-nuclear-factor-b-inhibitor/)

## Researcher topics

- [NF-κB Signaling Pathways](https://scholariq.org/topics/nf-b-signaling-pathways/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)
- [Immune Response and Inflammation](https://scholariq.org/topics/immune-response-and-inflammation/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Researcher university

- [University of Liège](https://scholariq.org/institutions/university-of-liege/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.